Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

August 28, 2009

Study Completion Date

August 28, 2009

Conditions

Healthy Volunteers

Interventions

DRUG

rHuPH20

recombinant human hyaluronidase PH20

DRUG

Insulin Human Injection

injection

DRUG

Insulin Lispro Injection

injection

Trial Locations (1)

dgd Research, Inc., San Antonio